Koninklijke Philips (PHG) Competitors

$25.52 -0.11 (-0.42%)

Closing price 05/14/2026 03:59 PM Eastern

Extended Trading

$25.16 -0.36 (-1.42%)

As of 04:35 AM Eastern

PHG vs. MDLN, GEHC, ZBH, SNN, and SOLV

Should you buy Koninklijke Philips stock or one of its competitors? MarketBeat compares Koninklijke Philips with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Koninklijke Philips include Medline (MDLN), GE HealthCare Technologies (GEHC), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), and Solventum (SOLV). These companies are all part of the "medical equipment" industry.

How does Koninklijke Philips compare to Medline?

Medline (NASDAQ:MDLN) and Koninklijke Philips (NYSE:PHG) are both large-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability.

Koninklijke Philips has lower revenue, but higher earnings than Medline.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medline	$28.43B	1.80	N/A	N/A	N/A
Koninklijke Philips	$20.17B	1.22	$1.01B	$1.17	21.81

13.7% of Koninklijke Philips shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Medline had 2 more articles in the media than Koninklijke Philips. MarketBeat recorded 6 mentions for Medline and 4 mentions for Koninklijke Philips. Medline's average media sentiment score of 0.33 beat Koninklijke Philips' score of 0.33 indicating that Medline is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medline	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Koninklijke Philips	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Medline currently has a consensus target price of $50.85, suggesting a potential upside of 30.71%. Given Medline's stronger consensus rating and higher probable upside, equities research analysts plainly believe Medline is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medline	0 Sell rating(s)	6 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.86
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Koninklijke Philips has a net margin of 5.49% compared to Medline's net margin of 0.00%. Koninklijke Philips' return on equity of 13.51% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medline	N/A	N/A	N/A
Koninklijke Philips	5.49%	13.51%	5.48%

Summary

Medline beats Koninklijke Philips on 8 of the 12 factors compared between the two stocks.

How does Koninklijke Philips compare to GE HealthCare Technologies?

GE HealthCare Technologies (NASDAQ:GEHC) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability.

GE HealthCare Technologies has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$20.63B	1.38	$2.08B	$4.18	14.99
Koninklijke Philips	$20.17B	1.22	$1.01B	$1.17	21.81

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, GE HealthCare Technologies had 9 more articles in the media than Koninklijke Philips. MarketBeat recorded 13 mentions for GE HealthCare Technologies and 4 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 1.07 beat Koninklijke Philips' score of 0.33 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	4 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

GE HealthCare Technologies currently has a consensus target price of $80.67, suggesting a potential upside of 28.72%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays an annual dividend of $0.86 per share and has a dividend yield of 3.4%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Koninklijke Philips pays out 73.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

GE HealthCare Technologies has a net margin of 9.10% compared to Koninklijke Philips' net margin of 5.49%. GE HealthCare Technologies' return on equity of 20.46% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.10%	20.46%	5.73%
Koninklijke Philips	5.49%	13.51%	5.48%

Summary

GE HealthCare Technologies beats Koninklijke Philips on 16 of the 18 factors compared between the two stocks.

How does Koninklijke Philips compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

Zimmer Biomet has a net margin of 9.05% compared to Koninklijke Philips' net margin of 5.49%. Koninklijke Philips' return on equity of 13.51% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.05%	13.24%	7.28%
Koninklijke Philips	5.49%	13.51%	5.48%

Zimmer Biomet has a beta of 0.48, suggesting that its stock price is 52% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.2%. Koninklijke Philips pays an annual dividend of $0.86 per share and has a dividend yield of 3.4%. Zimmer Biomet pays out 24.9% of its earnings in the form of a dividend. Koninklijke Philips pays out 73.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Koninklijke Philips has higher revenue and earnings than Zimmer Biomet. Zimmer Biomet is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	1.94	$705.20M	$3.85	21.48
Koninklijke Philips	$20.17B	1.22	$1.01B	$1.17	21.81

In the previous week, Zimmer Biomet had 7 more articles in the media than Koninklijke Philips. MarketBeat recorded 11 mentions for Zimmer Biomet and 4 mentions for Koninklijke Philips. Zimmer Biomet's average media sentiment score of 0.76 beat Koninklijke Philips' score of 0.33 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

88.9% of Zimmer Biomet shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Zimmer Biomet presently has a consensus target price of $102.80, indicating a potential upside of 24.29%. Given Zimmer Biomet's stronger consensus rating and higher probable upside, analysts clearly believe Zimmer Biomet is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	3 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.26
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Zimmer Biomet beats Koninklijke Philips on 13 of the 19 factors compared between the two stocks.

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

Koninklijke Philips has higher revenue and earnings than Smith & Nephew SNATS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	2.06	$625M	N/A	N/A
Koninklijke Philips	$20.17B	1.22	$1.01B	$1.17	21.81

In the previous week, Koninklijke Philips had 2 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 4 mentions for Koninklijke Philips and 2 mentions for Smith & Nephew SNATS. Smith & Nephew SNATS's average media sentiment score of 0.34 beat Koninklijke Philips' score of 0.33 indicating that Smith & Nephew SNATS is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew SNATS	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Koninklijke Philips	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Smith & Nephew SNATS has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

Smith & Nephew SNATS presently has a consensus target price of $30.93, indicating a potential upside of 4.11%. Given Smith & Nephew SNATS's stronger consensus rating and higher probable upside, analysts clearly believe Smith & Nephew SNATS is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.40
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Koninklijke Philips has a net margin of 5.49% compared to Smith & Nephew SNATS's net margin of 0.00%. Koninklijke Philips' return on equity of 13.51% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
Koninklijke Philips	5.49%	13.51%	5.48%

Smith & Nephew SNATS pays an annual dividend of $0.93 per share and has a dividend yield of 3.1%. Koninklijke Philips pays an annual dividend of $0.86 per share and has a dividend yield of 3.4%. Koninklijke Philips pays out 73.5% of its earnings in the form of a dividend.

25.6% of Smith & Nephew SNATS shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Smith & Nephew SNATS and Koninklijke Philips tied by winning 8 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to Solventum?

Koninklijke Philips (NYSE:PHG) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

Solventum has lower revenue, but higher earnings than Koninklijke Philips. Solventum is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.22	$1.01B	$1.17	21.81
Solventum	$8.33B	1.55	$1.56B	$8.16	9.12

In the previous week, Solventum had 2 more articles in the media than Koninklijke Philips. MarketBeat recorded 6 mentions for Solventum and 4 mentions for Koninklijke Philips. Solventum's average media sentiment score of 0.41 beat Koninklijke Philips' score of 0.33 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Solventum	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Koninklijke Philips has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market. Comparatively, Solventum has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

Solventum has a consensus target price of $83.36, indicating a potential upside of 12.05%. Given Solventum's stronger consensus rating and higher possible upside, analysts plainly believe Solventum is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solventum	1 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.46

Solventum has a net margin of 17.33% compared to Koninklijke Philips' net margin of 5.49%. Solventum's return on equity of 23.51% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	5.49%	13.51%	5.48%
Solventum	17.33%	23.51%	7.63%

13.7% of Koninklijke Philips shares are owned by institutional investors. 0.2% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Solventum beats Koninklijke Philips on 12 of the 16 factors compared between the two stocks.

Get Koninklijke Philips News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PHG vs. The Competition

Export

Metric	Koninklijke Philips	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$24.68B	$8.18B	$6.34B	$22.90B
Dividend Yield	3.36%	2.53%	2.80%	4.09%
P/E Ratio	21.87	15.80	20.66	30.78
Price / Sales	1.22	8.38	545.73	95.02
Price / Cash	8.29	16.82	43.26	25.31
Price / Book	1.84	3.63	9.94	4.67
Net Income	$1.01B	$223.05M	$3.55B	$1.06B
7 Day Performance	-6.06%	-1.07%	1.70%	-0.89%
1 Month Performance	-12.25%	1.86%	0.49%	1.42%
1 Year Performance	4.90%	2.20%	39.38%	24.64%

Koninklijke Philips Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PHG Koninklijke Philips	2.6234 of 5 stars	$25.52 -0.4%	N/A	+6.9%	$24.68B	$20.17B	21.87	65,340
MDLN Medline	4.2551 of 5 stars	$39.25 -0.7%	$50.69 +29.2%	N/A	$51.92B	$28.43B	N/A	43,000	Analyst Forecast
GEHC GE HealthCare Technologies	4.9523 of 5 stars	$61.70 -2.8%	$80.67 +30.7%	-14.0%	$28.87B	$20.63B	14.76	54,000	Insider Trade
ZBH Zimmer Biomet	4.5353 of 5 stars	$79.67 -3.2%	$102.80 +29.0%	-13.1%	$15.93B	$8.23B	20.69	17,000
SNN Smith & Nephew SNATS	2.6038 of 5 stars	$29.12 -2.8%	$30.93 +6.2%	+6.0%	$12.79B	$6.16B	N/A	16,988

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PHG) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Koninklijke Philips (PHG) Competitors

PHG vs. MDLN, GEHC, ZBH, SNN, and SOLV

How does Koninklijke Philips compare to Medline?

Summary

How does Koninklijke Philips compare to GE HealthCare Technologies?

Summary

How does Koninklijke Philips compare to Zimmer Biomet?

Summary

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Summary

How does Koninklijke Philips compare to Solventum?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Koninklijke Philips (PHG) Competitors

PHG vs. MDLN, GEHC, ZBH, SNN, and SOLV

How does Koninklijke Philips compare to Medline?

Which has stronger valuation & earnings, MDLN or PHG?

Do institutionals & insiders believe in MDLN or PHG?

Does the media favor MDLN or PHG?

Do analysts prefer MDLN or PHG?

Is MDLN or PHG more profitable?

Summary

How does Koninklijke Philips compare to GE HealthCare Technologies?

Which has more volatility & risk, GEHC or PHG?

Which has stronger earnings & valuation, GEHC or PHG?

Do insiders and institutionals hold more shares of GEHC or PHG?

Does the media prefer GEHC or PHG?

Do analysts prefer GEHC or PHG?

Is GEHC or PHG a better dividend stock?

Is GEHC or PHG more profitable?

Summary

How does Koninklijke Philips compare to Zimmer Biomet?

Is ZBH or PHG more profitable?

Which has more risk and volatility, ZBH or PHG?

Is ZBH or PHG a better dividend stock?

Which has higher valuation & earnings, ZBH or PHG?

Does the media favor ZBH or PHG?

Do insiders & institutionals believe in ZBH or PHG?

Do analysts prefer ZBH or PHG?

Summary

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Which has higher valuation & earnings, SNN or PHG?

Does the media favor SNN or PHG?

Which has more risk and volatility, SNN or PHG?

Do analysts prefer SNN or PHG?

Is SNN or PHG more profitable?

Is SNN or PHG a better dividend stock?

Do insiders & institutionals believe in SNN or PHG?

Summary

How does Koninklijke Philips compare to Solventum?

Which has higher earnings & valuation, PHG or SOLV?

Does the media refer more to PHG or SOLV?

Which has more volatility and risk, PHG or SOLV?

Do analysts recommend PHG or SOLV?

Is PHG or SOLV more profitable?

Do institutionals and insiders believe in PHG or SOLV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools